Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

FDA places M-Vax and O-Vax on clinical hold

March 28, 2001

Multiple-cytokine fusion proteins prepared at Lexigen for use in cancer

March 23, 2001

ProstaRex shows broad T-cell response in preclinical prostate cancer studies

March 15, 2001

Cell Genesys initiates phase I/II trial of GVAX cancer vaccine for multiple myeloma

March 8, 2001

AltaRex's OvaRex shows efficacy and safety in phase II trial

March 7, 2001

NeoPharm and NCI expand collaboration for anticancer agent

March 6, 2001

NeoPharm's CRADA agreement for IL-13 receptor research extended

March 1, 2001

Positive quality-of-life and survival results reported for Maxim's Ceplene

March 1, 2001

FDA requests further information for Campath BLA

Feb. 23, 2001

Vical broadens clinical development of Allovectin-7

Feb. 22, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...